Hyeon-Hoe Kim

Prof. Hyeon-Hoe Kim


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJa Hyun Ku
Ja Hyun Ku
MKMinyong Kang
Minyong Kang
HKHyung Suk Kim
Hyung Suk Kim
CJChang Wook Jeong
Chang Wook Jeong
CKCheol Kwak
Cheol Kwak
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
Although lymph node (LN) status and the LN burden determine the outcome of bladder cancer patients treated with cystectomy, compelling arguments have been made for the incorporation of LN density into the current staging system. Here, we investigate the relationship between LN density and clinical outcome in patients with LN-positive disease, following radical cystectomy for bladder cancer. PubMed, SCOPUS, the Institute for Scientific Information Web of Science, and the Cochrane Library were searched to identify relevant published literature. Fourteen studies were included in the meta-analysis, with a total number of 3311 patients. Of these 14 publications, 6 studies, (533 patients), 10 studies (2966 patients), and 5 studies (1108 patients) investigated the prognostic association of LN density with disease-free survival (DFS), disease-specific survival (DSS), and overall survival (OS), respectively. The pooled hazard ratio (HR) for DFS was 1.45 (95 % confidence interval [CI], 1.10–1.91) without heterogeneity (I2 = 0 %, p = 0.52). Higher LN density was significantly associated with poor DSS (pooled HR, 1.53; 95 % CI, 1.23–1.89). However, significant heterogeneity was found between studies (I2 = 66 %, p = 0.002). The pooled HR for OS was statistically significant (pooled HR, 1.45; 95 % CI, 1.11–1.90) without heterogeneity (I2 = 42 %, p = 0.14). The results of the Begg and Egger tests suggested that publication bias was not evident in this meta-analysis. The data from this meta-analysis indicate that LN density is an independent predictor of clinical outcome in LN-positive patients. LN density may be useful in future staging systems, thus allowing better prognostic classification of LN-positive bladder cancer.

13 January 2015 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
JKJ H Ku
J H Ku
MKM Kang
M Kang
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
CJC W Jeong
C W Jeong
CKC Kwak
C Kwak
HKH H Kim
H H Kim
Systemic inflammatory response (SIR) is important in the relationship between the tumour, the host, and outcome in cancer patients. However, limited data exist regarding the prognostic significance of SIR in bladder cancer. We investigate the utility of pretreatment SIR in patients with urothelial carcinoma undergoing radical cystectomy. The study cohort consisted of 419 patients with a median follow-up of 37.7 months. The SIRs used for each described prognostic nomogram are consistent with previously published data: C-reactive protein, albumin, white cell count, neutrophil count, lymphocyte count, and platelet count. Primary end point was disease-specific survival (DSS) and overall survival (OS) after surgery. Cox regression models were used to determine the time to disease-specific and overall mortality. Multivariate regression coefficients of the predictors were used to develop nomograms for predicting 5-year DSS and OS probability. Multivariate Cox regression analyses revealed that albumin, lymphocyte count, and platelet count were significantly associated with a significantly increased risk for death from bladder cancer. The nomograms including each index were developed to predict the probability of 5-year DSS and OS after radical cystectomy. The C statistics were 77.8% and 77.3%, respectively, and exceeded the 2002 AJCC (72.0% and 70.3%, respectively). In the decision curve analyses, the nomograms including SIR demonstrated higher net benefit gains compared with the models without SIR. Cellular components of SIR have better prognostic values compared with acute-phase protein in patients undergoing radical cystectomy for bladder cancer.

1 June 2010 in Journal of Endourology
Verified
Journal Article
Closed access
YPYong Hyun Park
Yong Hyun Park
JPJi Hyun Park
Ji Hyun Park
CJChang Wook Jeong
Chang Wook Jeong
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
Purpose: To compare the results of laparoendoscopic single-site (LESS) radical nephrectomy with conventional laparoscopic radical nephrectomy for localized renal-cell carcinoma (RCC). Patients and Methods: This study was designed as a matched case-controlled study from our institute's RCC database. Nineteen consecutive patients who were undergoing LESS radical nephrectomy were compared with 38 patients who were undergoing conventional laparoscopic radical nephrectomy. The matching process accounted for sex, age, operative side, and tumor size. Results: No significant differences were observed in mean operative time (190.8 vs 172.4 min, P = 0.249), estimated blood loss (143.2 vs 199.5 mL, P = 0.235), and complication rate (15.8% vs 21.1 %, P = 0.635) between the LESS and conventional laparoscopy groups. Postoperative hospital stay after LESS radical nephrectomy was 2.7 (2–4) days, compared with 3.9 (3–7) days in the conventional laparoscopy group (P < 0.001). Postoperative pain, as measured by visual analog scale at postoperative day 1 (4.7 vs 5.8 points, P = 0.001), 2 (3.4 vs 4.6 points, P < 0.001), and 3 (2.7 vs 4.0 points, P = 0.008) was significantly lower in the LESS group. Conclusion: LESS radical nephrectomy is a feasible and safe surgical option for localized RCC that demonstrates improved cosmetic outcomes and the additional benefits of decreased postoperative pain and decreased hospital stay.

1 April 2008 in Journal of Urology
Verified
Journal Article
Closed access
HPHyoung Keun Park
Hyoung Keun Park
BJByong Chang Jeong
Byong Chang Jeong
MSMi-Kyung Sung
Mi-Kyung Sung
MPMi-Young Park
Mi-Young Park
ECEun Young Choi
Eun Young Choi
JKJeong In Kim
Jeong In Kim
We investigated the effects of quercetin on renal tubular cell injury induced by oxalate and the inhibitory effects of quercetin on urinary crystal deposit formation in an animal model. MDCK cells (American Type Culture Collection, Manassas, Virginia) were incubated with different concentrations of oxalate with and without quercetin. MTT (Sigma) assays for cell viability, malondialdehyde and catalase activity were measured to investigate the antioxidant effect of quercetin. Male Sprague-Dawley rats were divided into 3 groups. Group 1 was fed standard rat chow. Groups 2 and 3 rats were fed standard chow supplemented with 3% sodium oxalate for 4 weeks. For the first 8 days in 4 weeks each rat in groups 2 and 3 also received gentamicin intramuscularly. Additionally, group 3 rats were administered quercetin for 4 weeks. Rats were sacrificed after 4 weeks, after which 24-hour urine collections and kidney removal were performed. In the renal tissue malondialdehyde, superoxide dismutase and catalase activity was measured. Bisected kidneys were examined under microscopy to determine the number of crystals. The viability of MDCK cells significantly decreased and malondialdehyde production increased in the presence of oxalate. However, co-exposure to quercetin inhibited the decrease in cell viability and inhibited the lipid peroxidation production induced by oxalate. In the animal study malondialdehyde production in group 3 significantly decreased compared to that in group 2. Catalase and superoxide dismutase activity was increased in group 3 compared to that in group 2. The number of crystals in kidneys in group 3 was decreased significantly compared to that in group 2. Quercetin has an inhibitory effect on urinary crystal deposit formation.

Verified
Journal Article
Open access
PDF file
MKMinyong Kang
Minyong Kang
CJChang Wook Jeong
Chang Wook Jeong
JKJa Hyun Ku
Ja Hyun Ku
CKCheol Kwak
Cheol Kwak
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
Statins are cholesterol reduction agents that exhibit anti-cancer activity in several human cancers. Because autophagy is a crucial survival mechanism for cancer cells under stress conditions, cooperative inhibition of autophagy acts synergistically with other anti-cancer drugs. Thus, this study investigates whether combined treatment of atorvastatin and autophagy inhibitors results in enhancing the cytotoxic effects of atorvastatin, upon human bladder cancer cells, T24 and J82, in vitro. To measure cell viability, we performed the EZ-Cytox cell viability assay. We examined apoptosis by flow cytometry using annexin-V/propidium iodide (PI and western blot using procaspase-3 and poly (ADP-ribose) polymerase (PARP) antibodies. To examine autophagy activation, we evaluated the co-localization of LC3 and LysoTracker by immunocytochemistry, as well as the expression of LC3 and p62/sequestosome-1 (SQSTM1) by western blot. In addition, we assessed the survival and proliferation of T24 and J82 cells by a clonogenic assay. We found that atorvastatin reduced the cell viability of T24 and J82 cells via apoptotic cell death and induced autophagy activation, shown by the co-localization of LC3 and LysoTracker. Moreover, pharmacologic inhibition of autophagy significantly enhanced atorvastatin-induced apoptosis in T24 and J82 cells. In sum, inhibition of autophagy potentiates atorvastatin-induced apoptotic cell death in human bladder cancer cells in vitro, providing a potential therapeutic approach to treat bladder cancer.

13 September 2013 in BJU International
Verified
Journal Article
Closed access
PDF file
KKKyungtae Ko
Kyungtae Ko
YPYoung H. Park
Young H. Park
JLJeong W. Lee
Jeong W. Lee
JKJa H. Ku
Ja H. Ku
CKCheol Kwak
Cheol Kwak
HKHyeon-Hoe Kim
Hyeon-Hoe Kim